Results 21 to 30 of about 122,550 (291)

Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents. [PDF]

open access: yesPLoS ONE, 2015
Ureteral obstruction caused by extrinsic compression is often associated with intra-abdominal cancers. Internal drainage with ureteral stents is typically the first-line therapy to relieve such obstructions.
Po-Ming Chow   +9 more
doaj   +1 more source

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT

open access: yesFrontiers in Oncology, 2022
BackgroundHepatocellular carcinoma (HCC) patients with main portal vein tumor thrombus (MPVTT) may be able to have TACE through stent implantation into the portal vein with thrombosis to recover portal blood flow.PurposeThe goal of this study was to ...
Wei Huang   +9 more
doaj   +1 more source

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. [PDF]

open access: yes, 2007
BACKGROUND: The safety of drug-eluting stents has been called into question by recent reports of increased stent thrombosis, myocardial infarction, and death.
Kirtane, Ajay J   +14 more
core   +1 more source

Iatrogenic Arteriovenous Fistula Following Femoral Access Precipitating High-Output Heart Failure

open access: yesJACC: Case Reports, 2021
Iatrogenic complications may manifest in a variety of ways. We present the case of an 86-year-old woman who underwent a percutaneous coronary intervention with a drug-eluting stent for non–ST-segment elevation myocardial infarction followed by leadless ...
Robert S. Zilinyi, MD   +3 more
doaj   +1 more source

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. [PDF]

open access: yes, 2009
BACKGROUND: There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal stents, in patients with ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI)
Brodie, Bruce R.   +23 more
core   +1 more source

To stent or not to stent?

open access: yesThe American Journal of Gastroenterology, 2000
Als Andreas Grüntzig am 16. September 1977 erstmals bei seinem ersten Patienten, eine perkutane transluminale koronare Angioplastie (PTCA) durchführte, erschien alles einfach [...]
Thomas F. Lüscher, G. Pedrazzini
openaire   +2 more sources

The Combination of Stent and Antiplatelet Therapy May Be Responsible of Parenchymal Magnetic Susceptibility Artifacts after Endovascular Procedure

open access: yesTomography, 2021
The aim was to assess the occurrence of magnetic susceptibility artifacts (MSA) following endovascular treatment of intracranial aneurysm by stent using susceptibility weighted imaging (SWI).
Fanny Bourhis-Guizien   +5 more
doaj   +1 more source

Stenting the Undeployed Stent

open access: yesJapanese Heart Journal, 2004
Undeployment of a stent which poses a potential risk for future events may become a serious problem in the catheter laboratory. Herewith, we present a case in which we successfully stented an undeployed stent in the distal right coronary artery.
Sag, Cemal   +3 more
openaire   +3 more sources

Clinical implications of inflammation in atheroma formation and novel therapies in cardiovascular diseases

open access: yesFrontiers in Cell and Developmental Biology, 2023
Cardiovascular diseases (CVD) are the leading causes of death and disability in the world. Among all CVD, the most common is coronary artery disease (CAD).
Shivan Barungi   +12 more
doaj   +1 more source

Stent fractures in the superficial femoral artery: predisposing factors and their implications

open access: yesJornal Vascular Brasileiro, 2022
Background Fractures in stents implanted in the superficial femoral artery (SFA) are recognized complications of endovascular management of this arterial territory.
Fernando Trés Silveira   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy